Evaluation of Anti-A and Anti-B Alloisogglutinin Titer in Group O Plateletpheresis Donors
Journal Title: International Journal Of Research In Medicine - Year 2016, Vol 5, Issue 4
Abstract
BACKGROUND: Platelet (PLT) transfusions need to take into account the issues that arise due to significant amounts of ABO antigen being present on the platelets surface and anti-ABO alloisogglutinins being present in the donor’s plasma. Although relatively rare, acute intravascular haemolytic transfusion reactions (AHTRs) have been caused by passive transfer of anti -A and anti–B antibodies, present in apheresis platelets (APs) of group O donors, across a minor ABO incompatibility (group A, B and AB recipients). AIM: (1) To evaluate anti-A and anti-B titers in the plasma of group O APs donors. (2)To define a critical value of “high-titer” based on our methodology. (3)To increase the awareness of medical staff on the potential risk of ABO-incompatible PLT transfusions. MATERIALS AND METHODS: In this current study we evaluated anti-A and anti-B titers in 30 plasma samples from group O APs donors. Their age ranged from 20 to 58 years old (mean age: 39.8±1.1). The determination of anti-A and anti-B antibodies, was performed using the tube titration method specifying IgM antibodies. RESULT: Our results showed that, anti-A titers ranged from 2 to 1024 (mean titer: 64), while anti-B titers ranged from 2 to 256 (mean titer: 32). Anti-A titers were significantly higher than anti-B (p <0.01). The critical value of “high-titer” for anti-A and anti-B antibodies, based on our method and internationally accepted criteria, was defined to be at least 64. The frequency of group O APs donors, with “high-titer” anti-A and anti-B was relatively high, 56.6% and 43.4% respectively. CONCLUSION: In conclusion, the risk of haemolysis from ABO-incompatible PLT components, due to passive transfused anti-A and / or anti-B alloisogglutinins, is small but present. Transfusion Service Personnel and Clinicians should be aware of the potential risk and they should always be alert and vigilant when it comes to ABO-incompatible platelet transfusions.
Authors and Affiliations
Chirag Chaudhari, Milind Dighe, Farzana Kothari , Swati Patel
Keywords
Related Articles
- EP ID EP453110
- DOI -
- Views 75
- Downloads 0
A Study of Metabolic Syndromes and Insulin Resistance in General Population
BACKGROUND: It has been witness that there is a paradigm shift of medical science in its therapeutic and preventive approaches for non-communicable diseases (NCDs). The research regarding NCDs focuses on detection of gen...
Role of Peripheral smear in early diagnosis of neonatal septicaemia: A three year study at P.D.U. Medical College, Rajkot
BACKGROUND: A study of 120 neonates with clinical suspicion of septicemia, admitted in neonatal intensive care unit of K. T. Sheth Children Hospital, Rajkot was carried out to study the role of peripheral smear, to ev...
Analysis of custody deaths of the year 2015 and 2016
BACKGROUND: Preventing torture in custody and ensuring strict compliance of its guidelines in custodial deaths is one of the important agenda of NHRC. This article presents data of 46 deaths in custody/prison in north Ma...
Sickle Cell Disease: Prevalence, Clinical Presentation and Prognosis in Tribes; Current Concepts and Unanswered Question
BACKGROUND: Sickle cell Disease is one of the most common severe monogenic disorder in the world. It is characterized by intermittent Vasoocclusive events and chronic Hemolytic Anemia. Patients clinically present with ea...
An u nusual case r eport of primary non hodgkin’s lymphoma of mandible
BACKGROUND: Mandible accounts for 0.6% for isolated Primary Non Hodgkin’s lymphoma (PNHL). HIV associated PNHL presents with advanced disease and extra nodal involvement in up to 90% of patients. In the mandible main s...